{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-050965","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2023-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.996579+00:00","generated_at":"2026-06-18T23:43:50.238229+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vaxcyte increases ATM equity offering capacity from $150M to $400M","bullets":["Amendment to Sales Agreement with Jefferies raises aggregate offering amount to $400M.","As of Feb 27, 2023, ~$137.8M had been sold under the prior $150M ATM program.","Material terms unchanged; sales made via at-the-market offerings on Nasdaq.","Shares registered under existing shelf registration statement; no obligation to sell."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-050965","json":"https://secwatch.observer/filing/0001193125-23-050965.json","markdown":"https://secwatch.observer/filing/0001193125-23-050965.md","text":"https://secwatch.observer/filing/0001193125-23-050965.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000119312523050965/0001193125-23-050965-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000119312523050965/d448993d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:43:50.238229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}